Patents by Inventor Ravindra Kumar

Ravindra Kumar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210319402
    Abstract: A system and method for configuring an application is described. The system identifies user collaboration data of users of an application. The user collaboration data indicates durations of collaborations between one or more users using the application. The system computes an influencer score of a first user based on the duration of collaborations between the first user and the other users. The system determines that the influencer score of the first user exceeds an influencer score threshold and generates a configuration setting of the application for the first user. The system applies the configuration setting to the application for the first user.
    Type: Application
    Filed: May 21, 2020
    Publication date: October 14, 2021
    Inventors: Sanjay Hemmige Ramaswamy, Jagadeesh Virupaksha Huliyar, Sreeram Nivarthi, Ritu Lakhotia, Vindana Madhuwantha, Apurva Bharatkumar Shah, Ganesh Jaiswal, Siddarth Rajendra Kumar, V. S. Srujana Oruganti, Vishnu Gajendran, Sai Sumana Pagidipalli, Sunil Kumar, Nimesh Ravindra Desai, Nishtha Mehrotra, Diego Fernando Suarez Castillo, Neha Parikh Shah, Aaron James Harrison, Tannaz Sattari Tabrizi, Aleksey Y. Ashikhmin, Carlos Andres Morales Torrado, Amit Prem Manghani, Sida Peng
  • Publication number: 20210308206
    Abstract: This disclosure provides ActRII-binding proteins such as anti-ActRIIA and anti-ActRIIB antibodies, and compositions and methods for making the ActRII-binding proteins. In certain aspects the ActRII-binding proteins inhibit, or antagonize ActRII activity. In addition, the disclosure provides compositions and methods for diagnosing and treating diseases and conditions associated muscle wasting; a fibrotic condition; an inflammatory, cardiovascular, pulmonary, musculoskeletal, neurologic, ocular, skeletal, autoimmune, or metabolic disease or condition; wound healing; and cancer, and other ActRII-mediated diseases and conditions.
    Type: Application
    Filed: April 15, 2021
    Publication date: October 7, 2021
    Inventors: Ravindra Kumar, Jonathan Belk, Asya Grinberg, Dianne Sako, Roselyne Castonguay
  • Publication number: 20210299220
    Abstract: In some aspects, the disclosure relates to GDF/BMP antagonists and methods of using GDF/BMP antagonists to treat, prevent, or reduce the progression rate and/or severity of pulmonary hypertension (PH), particularly treating, preventing or reducing the progression rate and/or severity of one or more PH-associated complications. The disclosure also provides methods of using a GDF/BMP antagonist to treat, prevent, or reduce the progression rate and/or severity of a variety of conditions including, but not limited to, pulmonary vascular remodeling, pulmonary fibrosis, and right ventricular hypertrophy. The disclosure further provides methods of using a GDF/BMP antagonist to reduce right ventricular systolic pressure in a subject in need thereof.
    Type: Application
    Filed: June 4, 2021
    Publication date: September 30, 2021
    Applicants: Acceleron Pharma Inc., Acceleron Pharma Inc.
    Inventors: Ravindra Kumar, John Knopf
  • Publication number: 20210300991
    Abstract: In certain aspects, the present disclosure relates to the insight that a polypeptide comprising a truncated, ligand-binding portion of the extracellular domain of endoglin (ENG) polypeptide may be used to inhibit angiogenesis in vivo, particularly in mammals suffering angiogenesis-related disorders.
    Type: Application
    Filed: March 18, 2021
    Publication date: September 30, 2021
    Applicant: Acceleron Pharma Inc.
    Inventors: Asya Grinberg, Roselyne Castonguay, Eric Werner, Ravindra Kumar
  • Publication number: 20210299216
    Abstract: In some aspects, the disclosure relates to GDF/BMP antagonists and methods of using GDF/BMP antagonists to treat, prevent, or reduce the progression rate and/or severity of pulmonary hypertension (PH), particularly treating, preventing or reducing the progression rate and/or severity of one or more PH-associated complications. The disclosure also provides methods of using a GDF/BMP antagonist to treat, prevent, or reduce the progression rate and/or severity of a variety of conditions including, but not limited to, pulmonary vascular remodeling, pulmonary fibrosis, and right ventricular hypertrophy. The disclosure further provides methods of using a GDF/BMP antagonist to reduce right ventricular systolic pressure in a subject in need thereof.
    Type: Application
    Filed: June 4, 2021
    Publication date: September 30, 2021
    Inventors: Ravindra Kumar, John Knopf
  • Patent number: 11130701
    Abstract: A method for laser processing a transparent workpiece includes forming a contour line that includes defects, by directing a pulsed laser beam output by a beam source through an aspheric optical element positioned offset in a radial direction from the beam pathway and into the transparent workpiece such that the portion of the pulsed laser beam directed into the transparent workpiece generates an induced absorption within the transparent workpiece that produces a defect within the transparent workpiece. The portion of the pulsed laser beam directed into the transparent workpiece includes a wavelength ?, an effective spot size wo,eff, and a non-axisymmetric beam cross section having a minimum Rayleigh range ZRx,min in an x-direction and a minimum Rayleigh range ZRy,min in a y-direction. Further, the smaller of ZRx,min and ZRy,min is greater than F D = ? ? ? w 0 , eff 2 ? , where FD is a dimensionless divergence factor comprising a value of 10 or greater.
    Type: Grant
    Filed: June 24, 2020
    Date of Patent: September 28, 2021
    Assignee: Corning Incorporated
    Inventors: Ravindra Kumar Akarapu, Garrett Andrew Piech, Sergio Tsuda, James Andrew West
  • Publication number: 20210294399
    Abstract: A device with automated device temperature control is described. In one example, the device includes a processor and a weather forecast engine coupled to the processor. The weather forecast engine obtains weather data of a geographical location in which the device is located. The weather data includes values of environmental parameters. The weather data is then shared with a prediction engine. The device further includes a control engine coupled to the processor. The control engine receives a first threshold operating temperature determined for the device based on the weather data, a device model, and a mapping table from the prediction engine. The control engine then initiates a temperature control device, connected to the device, to cool the device if a current device temperature of the device is greater than the first threshold operating temperature.
    Type: Application
    Filed: March 16, 2021
    Publication date: September 23, 2021
    Inventors: Dipak Belvant More, Abhishek Ashokkumar Jangid, Narendra Kumar Chincholikar, Ravindra Ramtekkar
  • Patent number: 11123430
    Abstract: In certain aspects, the present disclosure provides compositions and methods for increasing red blood cell and/or hemoglobin levels in a subject in need thereof. Subjects in need include, for example, subjects having anemia and/or ineffective erythropoiesis as a result of having reduced GATA-1, heat shock factor and/or NFE2 levels as compared to the levels in a reference population.
    Type: Grant
    Filed: November 4, 2016
    Date of Patent: September 21, 2021
    Assignee: ACCELERON PHARMA INC.
    Inventors: Ravindra Kumar, Pedro Martinez, Naga Venkata Sai Rajasekhar Suragani
  • Publication number: 20210277082
    Abstract: In certain aspects, the present invention provides compositions and methods for increasing red blood cell and/or hemoglobin levels in vertebrates, including rodents and primates, and particularly in humans.
    Type: Application
    Filed: October 6, 2020
    Publication date: September 9, 2021
    Inventors: Ravindra Kumar, Naga Venkata Sai Rajasekhar Suragani, John Knopf
  • Patent number: 11113266
    Abstract: This disclosure relates generally to detection of inconsistencies in Semantics of Business Vocabulary and Business Rules (SBVR) rules, and, more particularly, to detecting inconsistencies in SBVR using Many-Sorted Logic. Traditional systems and methods implementing graphical and other related techniques are not sufficient to detect anomalies in semantic rules, thereby leading to a different verification approach to detect logical anomalies and errors due to quantification. Embodiment of the present disclosure overcome the limitations faced by the traditional systems and methods by translating a set of SBVR rules into a SBVR eXtensible Markup Language Metadata Interchange (XMI); transforming the SBVR XMI into one or more Satisfiability Modulo Theories Library (SMT-LIB) formulas using at least one logical structure and semantic of Many-Sorted Logic; and detecting, from the one or more SMT-LIB formulas, one or more inconsistencies in semantics of SBVR by using a SMT solver invocation.
    Type: Grant
    Filed: June 5, 2019
    Date of Patent: September 7, 2021
    Assignee: Tata Consultancy Services Limited
    Inventors: Pavan Kumar Chittimalli, Ravindra Naik, Kritika Anand
  • Publication number: 20210261682
    Abstract: In certain aspects, the present invention provides compositions and methods for promoting bone growth and increasing bone density, as well as for the treatment of multiple myeloma.
    Type: Application
    Filed: October 15, 2020
    Publication date: August 26, 2021
    Inventors: John Knopf, Jasbir Seehra, Ravindra Kumar
  • Publication number: 20210253658
    Abstract: In certain aspects, the present invention provides compositions and methods for increasing red blood cell and/or hemoglobin levels in vertebrates, including rodents and primates, and particularly in humans.
    Type: Application
    Filed: September 25, 2020
    Publication date: August 19, 2021
    Inventors: Jasbir Seehra, Robert Scott Pearsall, Ravindra Kumar
  • Publication number: 20210230252
    Abstract: In certain aspects, the present disclosure relates to polypeptides comprising a truncated, ligand-binding portion of the extracellular domain of T?RII polypeptide useful to selectively antagonize a T?RII ligand. The disclosure further provides compositions and methods for use in treating or preventing TGF? associated disorders.
    Type: Application
    Filed: April 13, 2021
    Publication date: July 29, 2021
    Inventors: Ravindra Kumar, Asya Grinberg, Dianne S. Sako, Roselyne Castonguay, Rita Steeves
  • Publication number: 20210224372
    Abstract: Methods and systems for managing unlocking of an electronic device are provided. A method includes receiving an unlocking input from a user, authenticating the unlocking input, generating a first pre-wakeup command of initializing a progress action for the electronic device, generating a second pre-wakeup command of whether to complete the progress action or to retrogress the progress action based on the authenticating of the unlocking input, and determining whether to unlock the electronic device based on the second pre-wakeup command.
    Type: Application
    Filed: July 18, 2019
    Publication date: July 22, 2021
    Inventors: Hari Krishnan Thiruvalli VENUGOPALAN, Mineni NISWANTH BABU, Gaurav GUPTA, Sri Lakshmi PUNURU, Gopinath CHENNAKESWARAN, Ashish Kumar SINGH, Ravindra Kumar MISHRA, Rajaram Hanumantacharya NAGANUR
  • Patent number: 11066654
    Abstract: In certain aspects, the present invention provides compositions and methods for modulating (promoting or inhibiting) growth of a tissue, such as bone, cartilage, muscle, fat, brown fat and/or neuronal tissue and for treating metabolic disorders such as diabetes and obesity, as well as disorders associated with any of the foregoing tissue.
    Type: Grant
    Filed: June 7, 2019
    Date of Patent: July 20, 2021
    Assignee: ACCELERON PHARMA INC.
    Inventors: Jasbir Seehra, Ravindra Kumar
  • Patent number: 11065303
    Abstract: In some aspects, the disclosure relates to GDF/BMP antagonists and methods of using GDF/BMP antagonists to treat, prevent, or reduce the progression rate and/or severity of pulmonary hypertension (PH), particularly treating, preventing or reducing the progression rate and/or severity of one or more PH-associated complications. The disclosure also provides methods of using a GDF/BMP antagonist to treat, prevent, or reduce the progression rate and/or severity of a variety of conditions including, but not limited to, pulmonary vascular remodeling, pulmonary fibrosis, and right ventricular hypertrophy. The disclosure further provides methods of using a GDF/BMP antagonist to reduce right ventricular systolic pressure in a subject in need thereof.
    Type: Grant
    Filed: August 25, 2020
    Date of Patent: July 20, 2021
    Assignee: ACCELERON PHARMA INC.
    Inventors: Ravindra Kumar, John Knopf
  • Patent number: 11059894
    Abstract: This disclosure provides ALK7-binding proteins such as anti-ALK7 antibodies, and compositions and methods for making the ALK7-binding proteins. In certain embodiments the ALK7-binding proteins inhibit, or antagonize ALK7 activity. In addition, the disclosure provides compositions and methods for diagnosing and treating overweight, obesity, diabetes, overweight, obesity, type 2 diabetes, and their associated conditions; metabolic disorders, and other diseases or conditions that can be treated, prevented or ameliorated by targeting ALK7.
    Type: Grant
    Filed: November 26, 2019
    Date of Patent: July 13, 2021
    Assignee: Acceleron Pharma Inc.
    Inventors: John Knopf, Jonathan Belk, Nathan J. Sharkey, Ravindra Kumar, Asya Grinberg, Dianne Sako, Roselyne Castonguay, Yossi Dagon
  • Publication number: 20210207107
    Abstract: In certain aspects, the present invention provides compositions and methods for increasing red blood cell and/or hemoglobin levels in vertebrates, including rodents and primates, and particularly in humans.
    Type: Application
    Filed: August 7, 2020
    Publication date: July 8, 2021
    Inventors: Jasbir Seehra, Robert Scott Pearsall, Ravindra Kumar, Naga Venkata Sai Rajasekhar Suragani
  • Publication number: 20210188955
    Abstract: In certain aspects, the present disclosure provides compositions and methods for increasing red blood cell and/or hemoglobin levels in vertebrates, including rodents and primates, and particularly in humans. In some embodiments, the compositions of the disclosure may be used to treat or prevent sickle-cell disease or one or more complications associated with sickle-cell disease.
    Type: Application
    Filed: August 10, 2020
    Publication date: June 24, 2021
    Inventors: Ravindra Kumar, Naga Venkata Sai Rajasekhar Suragani
  • Publication number: 20210177741
    Abstract: The disclosure provides, in part, follistatin polypeptides that are suitable for use in local administration and methods for use.
    Type: Application
    Filed: July 30, 2020
    Publication date: June 17, 2021
    Inventors: Ravindra Kumar, Asya Grinberg